Primetaz: Enhancing MRI performance through innovative tech and materials in medical imaging.
Primetaz, founded with a mission to revolutionize medical imaging, focuses on enhancing MRI performance through innovative technology and materials. The company leverages metamaterials—artificially-designed materials with unique properties—to improve the signal-to-noise ratio (SNR) in MRI systems. By integrating fundamental science, engineering, and medicine, Primetaz aims to create a metamaterial-enabled platform that significantly boosts the efficiency and clarity of MRI scans, targeting the healthcare and medical imaging markets.
Notable figures associated with Primetaz include leading scientists and engineers specializing in metamaterials and medical imaging. The company has attracted investment from prominent venture capital firms interested in cutting-edge healthcare technologies. Key achievements include the successful development of metamaterials compatible with clinical MRI systems, resulting in enhanced imaging capabilities. Primetaz's impact is marked by its potential to transform diagnostic imaging, offering more precise and reliable results for medical professionals and patients alike.
Primetaz's most recent funding round was for $256k (USD) in March 2021.
As of Mar 31, 2021, Primetaz has disclosed funding of $256k (USD).

Gencores
gencores.com

Multiscale Systems

PETcoil
petcoil.com

Notch
Alpha-MRI

Metamagnetics
metamag.us

Magnetic Insight

Gel4Med
gelformed.com

Magnet Biomedicine
magnetbio.com

Imaginostics
imaginostics.com

Matterworks
matterworksbio.com

Promaxo
promaxo.com

Taproot Medical Technologies
taprootmedical.com
Abri Science

Mitogenetics
mitogenetics.com

Tetramer Technologies
tetramer.com

Maxterial
maxterial.com
Serometrix

Metaphore Biotechnologies
metaphorebio.com

TissueForm
tissueforminc.com